Showing results (711-720 of 1,344) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|July 1, 2015
CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsyA Ortega-Vázquez, P Dorado, I Fricke-Galindo, et al.The Pharmacogenomics Journal|July 1, 2015
Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptomsS Mas, P Gassó, D Boloc, et al.The Pharmacogenomics Journal|July 1, 2015
Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysisL E Salnikova, D S KolobkovThe Pharmacogenomics Journal|May 20, 2015
A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohortP M Bet, E C Verbeek, Y Milaneschi, et al.The Pharmacogenomics Journal|July 15, 2015
A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced coughJ D Mosley, C M Shaffer, S L Van Driest, et al.The Pharmacogenomics Journal|May 6, 2015
PGMD: a comprehensive manually curated pharmacogenomic databaseA Kaplun, J D Hogan, F Schacherer, et al.The Pharmacogenomics Journal|October 23, 2019
Meta-analysis of the associations of CYP2B6-516G>T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV-infected adultsLin Cheng, Yu Wang, Xiaoyu Li, et al.The Pharmacogenomics Journal|October 20, 2019
Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteersPablo Zubiaur, Miriam Saiz-Rodríguez, Dolores Ochoa, et al.The Pharmacogenomics Journal|June 17, 2015
CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitorsX Wang, G Wang, J Shi, et al.The Pharmacogenomics Journal|August 12, 2021
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trialJoseph P Schacht, Michaela Hoffman, Brian H Chen, et al.Pageof 135